A synthetic eicosanoid LX‐mimetic unravels host‐donor interactions in allogeneic BMT‐induced GvHD to reveal an early protective role for host neutrophils
暂无分享,去创建一个
[1] C. Serhan,et al. Resolvins , 2002, The Journal of experimental medicine.
[2] H. Rabb,et al. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. , 2002, Journal of the American Society of Nephrology : JASN.
[3] Sander Kersten,et al. Roles of PPARs in health and disease , 2000, Nature.
[4] Carl Nathan,et al. Points of control in inflammation , 2002, Nature.
[5] C. Serhan. Lipoxin biosynthesis and its impact in inflammatory and vascular events. , 1994, Biochimica et biophysica acta.
[6] J. Wallace,et al. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[7] Eugene Y. Kim,et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.
[8] C. Serhan,et al. Aspirin‐triggered lipoxin A4 and lipoxin A4 up‐regulate transcriptional corepressor NAB1 in human neutrophils , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] M. Perretti,et al. Annexin 1 and the biology of the neutrophil , 2004, Journal of leukocyte biology.
[10] S. Mitchell,et al. Lipoxins: revelations on resolution. , 2001, Trends in pharmacological sciences.
[11] A. Young,et al. Lipoxin A4 Analogs Attenuate Induction of Intestinal Epithelial Proinflammatory Gene Expression and Reduce the Severity of Dextran Sodium Sulfate-Induced Colitis1 , 2002, The Journal of Immunology.
[12] Garret A. FitzGerald,et al. COX-2 and beyond: approaches to prostaglandin inhibition in human disease , 2003, Nature Reviews Drug Discovery.
[13] M. Sykes,et al. Bone marrow chimerism and transplantation tolerance. , 1997, Current opinion in immunology.
[14] C. Serhan,et al. Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis , 1999, The Journal of experimental medicine.
[15] R. Korngold,et al. Recent advances in graft‐versus‐host disease (GVHD) prevention , 1997, Immunological reviews.
[16] J. Wallace,et al. A magic bullet for mucosal protection...and aspirin is the trigger! , 2003, Trends in pharmacological sciences.
[17] C. Serhan,et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] R. Bronson,et al. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. , 2000, The Journal of clinical investigation.
[19] R. Bronson,et al. Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. , 2003, The Journal of clinical investigation.
[20] C. Clish,et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Funk,et al. Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.